Marshall Schwartz to Apoptosis
This is a "connection" page, showing publications Marshall Schwartz has written about Apoptosis.
Connection Strength
0.435
-
Kuenzler KA, Pearson PY, Schwartz MZ. Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischemia-reperfusion. J Pediatr Surg. 2002 Jul; 37(7):1093-7; discussion 1093-7.
Score: 0.179
-
Weis VG, Deal AC, Mekkey G, Clouse C, Gaffley M, Whitaker E, Peeler CB, Weis JA, Schwartz MZ, Atala A. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2021 04 01; 320(4):G658-G674.
Score: 0.162
-
Katz MS, Thatch KA, Schwartz MZ. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. J Surg Res. 2010 Oct; 163(2):294-8.
Score: 0.077
-
Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease. J Pediatr Surg. 2008 Dec; 43(12):2169-73.
Score: 0.017